A2b adenosine receptors in cardioprotection: Timing is everything

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 3, 2011, Pages 582-583

  Methner, Carmen ^a   Krieg, Thomas ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2B RECEPTOR; AMINOPYRIDINE DERIVATIVE; BAY 60 6583; BAY 60-6583; CARDIOTONIC AGENT;

HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISCHEMIC PRECONDITIONING; KNOCKOUT MOUSE; LETTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT; REPERFUSION INJURY;

AMINOPYRIDINES; ANIMALS; CARDIOTONIC AGENTS; DRUG ADMINISTRATION SCHEDULE; ISCHEMIC PRECONDITIONING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL REPERFUSION INJURY; RECEPTOR, ADENOSINE A2B; REPERFUSION INJURY;

EID: 79551581445     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.10.031     Document Type: Letter

References (4)

1. 2B adenosine receptor. J Mol Cell Cardiol 2010, 49:886-893.
2. 2B adenosine receptors. Circulation 2007, 115:1581-1590.
3. 2b adenosine receptors at reperfusion are necessary to reduce infarct size in mouse hearts. Am J Physiol Heart Circ Physiol 2010, 299:H1262-H1264.
4. Murry C.E., Jenning R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74:1124-1136.